Volivris tablets 2.5 mg by GlaxoSmithKline contain ambrisentan, an endothelin receptor antagonist used for treating pulmonary arterial hypertension (PAH) in adults by helping to widen the pulmonary arteries (YJ code: 2190031F1023, standard: 2.5 mg 1 tablet).
Volivris tablets 2.5 mg
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).
